Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Drug Transporters and Adverse Drug Reactions in Veterinary Patients

Gastmeier Deja

Adverse drug reactions (ADRs) are a critical concern in veterinary medicine, impacting patient health and treatment outcomes. This paper explores the role of drug transporters in influencing ADRs in veterinary patients. Drug transporters are integral membrane proteins responsible for the movement of drugs into and out of cells, affecting drug disposition, efficacy, and safety. In veterinary medicine, understanding the interplay between drug transporters and ADRs is essential for optimizing drug therapy. This review highlights key drug transporters such as P-glycoprotein, multidrug resistanceassociated proteins, and organic anion transporters, emphasizing their significance in drug pharmacokinetics and disposition in various animal species. We discuss the impact of genetic variability in drug transporter genes on individual patient responses to medications, which can lead to variability in ADRs. Additionally, we examine the influence of drugdrug interactions on drug transporter function and its subsequent effects on ADRs. Furthermore, the paper discusses strategies for assessing drug transporter involvement in veterinary ADRs, including in vitro studies, pharmacogenomic approaches, and clinical monitoring techniques. These strategies can aid veterinarians in identifying patients at risk of ADRs and making informed treatment decisions.